Amway to Sell Interleukin Genetics Health Tests | GenomeWeb

NEW YORK (GenomeWeb News) – Interleukin Genetics said today that it has signed an agreement allowing members of Amway Global to sell some of its genetic tests, and that Amway will help in marketing the tests through its organization.

The agreement covers Interleukin Genetics' Inherent Health testing line, including tests for weight management, heart health, nutrition, and bone health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.